- HKIC supports Beijing's innovation agenda and seeks to bridge US and Chinese pharmaceutical markets.
Revised laws in China provide institutional support for the country's pharmaceutical industry and innovation agenda.
1 report, 1 independent
Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Revised laws in China provide institutional support for the country's pharmaceutical industry and innovation agenda.